{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T06:58:40Z","timestamp":1771484320284,"version":"3.50.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009465","name":"CORFO","doi-asserted-by":"publisher","award":["16IDAE-67701"],"award-info":[{"award-number":["16IDAE-67701"]}],"id":[{"id":"10.13039\/100009465","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biotechnology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jbiotec.2021.06.025","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T11:29:50Z","timestamp":1625225390000},"page":"52-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Expression and characterization of a novel single-chain anti-vascular endothelial growth factor antibody in the goat milk"],"prefix":"10.1016","volume":"338","author":[{"given":"Mar\u00eda J.","family":"Leiva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie C.","family":"Parra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1804-8331","authenticated-orcid":false,"given":"Mar\u00eda A.","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3919-161X","authenticated-orcid":false,"given":"Kaio C.S.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Macaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7885-7408","authenticated-orcid":false,"given":"Leonardo","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa\u00fal","family":"Gaudencio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0600-5243","authenticated-orcid":false,"given":"\u00c1ngela","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8436-3866","authenticated-orcid":false,"given":"Radoslaw P.","family":"Kozak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4352-4184","authenticated-orcid":false,"given":"Ala\u00edn","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliberto","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge R.","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Montesino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbiotec.2021.06.025_bib0005","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/980250","article-title":"scFv antibody: principles and clinical application","volume":"2012","author":"Ahmad","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0010","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00280-013-2298-3","article-title":"The VEGF pathway in lung cancer","volume":"72","author":"Alevizakos","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jgeb.2017.10.003","article-title":"Production and purification of IgY antibodies from chicken egg yolk","volume":"16","author":"Amro","year":"2018","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0020","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nprot.2011.435","article-title":"Use of the mouse aortic ring assay to study angiogenesis","volume":"7","author":"Baker","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0030","doi-asserted-by":"crossref","DOI":"10.1080\/19932820.2017.1290741","article-title":"The effect of vascular endothelial growth factor-1 expression on survival of advanced colorectal cancer patients","volume":"12","author":"Bendardaf","year":"2017","journal-title":"Libyan J. Med."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0035","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11248-016-9933-9","article-title":"The transgenic animal platform for biopharmaceutical production","volume":"25","author":"Bertolini","year":"2016","journal-title":"Transgenic Res."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0040","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.biotechadv.2017.03.011","article-title":"Very-large-scale production of antibodies in plants: the biologization of manufacturing","volume":"35","author":"Buyel","year":"2017","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0045","article-title":"Functional production of a soluble and secreted single-chain antibody by a bacterial secretion system","volume":"9","author":"Cheng","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0050","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0167-7799(03)00190-2","article-title":"Making recombinant proteins in animals--different systems, different applications","volume":"21","author":"Dyck","year":"2003","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0055","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s001099900019","article-title":"Molecular and biological properties of vascular endothelial growth factor","volume":"77","author":"Ferrara","year":"1999","journal-title":"J. Mol. Med. (Berl.)."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0060","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nrc909","article-title":"VEGF and the quest for tumour angiogenesis factors","volume":"2","author":"Ferrara","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0065","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1381","article-title":"Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer","volume":"3","author":"Ferrara","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0070","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1021\/bp060187j","article-title":"High-level recombinant protein production in CHO cells using an adenoviral vector and the cumate gene-switch","volume":"23","author":"Gaillet","year":"2007","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0075","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0080","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1002\/pmic.200900096","article-title":"Proposal for a standard system for drawing structural diagrams of N- and O-linked carbohydrates and related compounds","volume":"9","author":"Harvey","year":"2009","journal-title":"Proteomics"},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0085","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejpb.2016.01.005","article-title":"N-glycosylation heterogeneity and the influence on structure, function and pharmacokinetics of monoclonal antibodies and Fc fusion proteins","volume":"100","author":"Higel","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0090","first-page":"8","article-title":"Production and evaluation of specific single-chain antibodies against CTLA-4 for cancer-targeted therapy","volume":"6","author":"Hosseinzadeh","year":"2017","journal-title":"Rep. Biochem. Mol. Biol."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0095","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0300-9084(02)00012-3","article-title":"Animal transgenesis: recent data and perspectives","volume":"84","author":"Houdebine","year":"2002","journal-title":"Biochimie"},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.20506\/rst.37.1.2746","article-title":"Production of pharmaceutical proteins by transgenic animals","volume":"37","author":"Houdebine","year":"2018","journal-title":"Rev Sci Tech."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0105","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0110","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/bab.1617","article-title":"Progress in biopharmaceutical development","volume":"65","author":"Kesik-Brodacka","year":"2018","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0115","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jbiotec.2015.06.388","article-title":"Developing the biofacility of the future based on continuous processing and single-use technology","volume":"213","author":"Klutz","year":"2015","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0120","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0958-1669(97)80033-X","article-title":"Adenoviral vectors for gene transfer","volume":"8","author":"Kovesdi","year":"1997","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0125","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ab.2015.06.006","article-title":"Comparison of procainamide and 2-aminobenzamide labeling for profiling and identification of glycans by liquid chromatography with fluorescence detection coupled to electrospray ionization-mass spectrometry","volume":"486","author":"Kozak","year":"2015","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0130","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1007\/s00253-016-7388-9","article-title":"Advances in recombinant antibody manufacturing","volume":"100","author":"Kunert","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0135","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0140","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3390\/ijms17020214","article-title":"Generation of potent anti-vascular endothelial growth factor neutralizing antibodies from mouse phage display library for cancer therapy","volume":"17","author":"Lai","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0145","article-title":"Transgenic goats producing an improved version of cetuximab in milk","author":"Laible","year":"2020","journal-title":"bioRxiv."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nbt.2020.11.001","article-title":"In vivo modification of the goat mammary gland glycosylation pathway","volume":"61","author":"Leiva-Carrasco","year":"2021","journal-title":"N. Biotechnol."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0155","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.2479986","article-title":"Vascular endothelial growth factor is a secreted angiogenic mitogen","volume":"246","author":"Leung","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/1380-2933(95)00010-0","article-title":"Production of active anti-CD6 mouse\/human chimeric antibodies in the milk of transgenic mice","volume":"1","author":"Limonta","year":"1995","journal-title":"Immunotechnology."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0165","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1002\/cbic.202000201","article-title":"Anthrax protective antigen retargeted with single-chain variable fragments delivers enzymes to pancreatic cancer cells","volume":"21","author":"Loftis","year":"2020","journal-title":"Chembiochem."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-019-0592-z","article-title":"Development of therapeutic antibodies for the treatment of diseases","volume":"27","author":"Lu","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0175","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbagen.2007.11.003","article-title":"The Galalpha1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevance","volume":"1780","author":"Macher","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0180","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.3892\/ijo.2016.3709","article-title":"Antiangiogenic cancer treatment: the great discovery and greater complexity (Review)","volume":"49","author":"Maj","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0185","doi-asserted-by":"crossref","first-page":"33","DOI":"10.32607\/20758251-2013-5-1-33-46","article-title":"Use of transgenic animals in biotechnology: prospects and problems","volume":"5","author":"Maksimenko","year":"2013","journal-title":"Acta Naturae"},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0190","doi-asserted-by":"crossref","DOI":"10.5812\/jjm.16241","article-title":"Single chain antibodies against gp55 of human cytomegalovirus (HCMV) for prophylaxis and treatment of HCMV infections","volume":"9","author":"Moazen","year":"2016","journal-title":"Jundishapur J. Microbiol."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0195","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.abb.2007.11.019","article-title":"Monosialylated biantennary N-glycoforms containing GalNAc-GlcNAc antennae predominate when human EPO is expressed in goat milk","volume":"470","author":"Montesino","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0200","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1021\/pr800725v","article-title":"N-glycosylation pattern of E2 glycoprotein from classical swine fever virus","volume":"8","author":"Montesino","year":"2009","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0205","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/839831","article-title":"Antiproliferative and apoptotic effects of a specific antiprostate stem cell single chain antibody on human prostate cancer cells","volume":"2013","author":"Nejatollahi","year":"2013","journal-title":"J. Oncol."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0210","doi-asserted-by":"crossref","first-page":"7887","DOI":"10.1007\/s13277-014-1854-8","article-title":"Triple blockade of HER2 by a cocktail of anti-HER2 scFv antibodies induces high antiproliferative effects in breast cancer cells","volume":"35","author":"Nejatollahi","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0215","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0022-1759(99)00154-4","article-title":"Antitransferrin receptor antibody-RNase fusion protein expressed in the mammary gland of transgenic mice","volume":"231","author":"Newton","year":"1999","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0220","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-1759(99)00151-9","article-title":"Transgenic milk as a method for the production of recombinant antibodies","volume":"231","author":"Pollock","year":"1999","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0225","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.exer.2015.12.014","article-title":"Response to anti-VEGF-A treatment of endothelial cells in vitro","volume":"146","author":"Puddu","year":"2016","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0230","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/biot.201100455","article-title":"Biosafety evaluation of recombinant protein production in goat mammary gland using adenoviral vectors: preliminary study","volume":"7","author":"Rodriguez","year":"2012","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0235","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/107327480200902S05","article-title":"Clinical experience with angiogenesis signaling inhibitors: focus on vascular endothelial growth factor (VEGF) blockers","volume":"9","author":"Rosen","year":"2002","journal-title":"Cancer control: J. Moffitt Cancer Center"},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0240","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/abio.2002.5619","article-title":"An analytical and structural database provides a strategy for sequencing O-glycans from microgram quantities of glycoproteins","volume":"304","author":"Royle","year":"2002","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0245","first-page":"125","article-title":"Detailed structural analysis of N-glycans released from glycoproteins in SDS-PAGE gel bands using HPLC combined with exoglycosidase array digestions","volume":"347","author":"Royle","year":"2006","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0250","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.bbagen.2015.04.012","article-title":"Post-translational modification of a chimeric EPO-Fc hormone is more important than its molecular size in defining its in vivo hematopoietic activity","volume":"1850","author":"Salgado","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0255","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jbiotec.2004.06.009","article-title":"Adenoviral vector mediates high expression levels of human growth hormone in the milk of mice and goats","volume":"114","author":"Sanchez","year":"2004","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160345","article-title":"Generation and characterization of an IgG4 monomeric fc platform","volume":"11","author":"Shan","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0265","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.biologicals.2014.08.005","article-title":"Production and characterization of single-chain antibody (scFv) against 3ABC non-structural protein in Escherichia coli for sero-diagnosis of foot and mouth disease virus","volume":"42","author":"Sharma","year":"2014","journal-title":"Biologicals."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0270","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.tibtech.2013.10.002","article-title":"Microbials for the production of monoclonal antibodies and antibody fragments","volume":"32","author":"Spadiut","year":"2014","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0275","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jbiotec.2005.10.019","article-title":"High expression level of recombinant human erythropoietin in the milk of non-transgenic goats","volume":"123","author":"Toledo","year":"2006","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0280","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jbiotec.2007.09.014","article-title":"Highly protective E2-CSFV vaccine candidate produced in the mammary gland of adenoviral transduced goats","volume":"133","author":"Toledo","year":"2008","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0285","series-title":"FDA Approves Additional Treatment for Adults and Adolescents with Hemophilia a or B and Inhibitors","author":"US_FDA","year":"2020"},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0290","first-page":"1016","article-title":"VEGF inhibitors in renal cell carcinoma","volume":"14","author":"Vachhani","year":"2016","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0295","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(09)60251-8","article-title":"Monoclonal antibodies for cancer immunotherapy","volume":"373","author":"Weiner","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0300","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1073\/pnas.91.10.4407","article-title":"Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy","volume":"91","author":"Yang","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0305","first-page":"3941","article-title":"Clinical study on the medical value of combination therapy involving adoptive immunotherapy and chemotherapy for stage IV colorectal cancer (COMVI study)","volume":"37","author":"Yoshida","year":"2017","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0310","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.intimp.2014.10.015","article-title":"Induction of anti-proliferative and apoptotic effects by anti-IL-25 receptor single chain antibodies in breast cancer cells","volume":"23","author":"Younesi","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0315","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s11248-012-9589-z","article-title":"Functional recombinant human anti-HBV antibody expressed in milk of transgenic mice","volume":"21","author":"Zhang","year":"2012","journal-title":"Transgenic Res."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0320","doi-asserted-by":"crossref","first-page":"13208","DOI":"10.1038\/s41598-018-31417-2","article-title":"A novel glycosylated anti-CD20 monoclonal antibody from transgenic cattle","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0325","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1634\/theoncologist.2014-0465","article-title":"Targeting angiogenesis in cancer therapy: moving beyond vascular endothelial growth factor","volume":"20","author":"Zhao","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.jbiotec.2021.06.025_bib0330","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1039\/C9NR04976B","article-title":"Nanoparticles modified by triple single chain antibodies for MRI examination and targeted therapy in pancreatic cancer","volume":"12","author":"Zou","year":"2020","journal-title":"Nanoscale"}],"container-title":["Journal of Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168165621001851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168165621001851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T12:56:23Z","timestamp":1759150583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168165621001851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":66,"alternative-id":["S0168165621001851"],"URL":"https:\/\/doi.org\/10.1016\/j.jbiotec.2021.06.025","relation":{},"ISSN":["0168-1656"],"issn-type":[{"value":"0168-1656","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression and characterization of a novel single-chain anti-vascular endothelial growth factor antibody in the goat milk","name":"articletitle","label":"Article Title"},{"value":"Journal of Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbiotec.2021.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}